Profile
Pamela Holland worked as the Vice President of Cancer Biology at Surface Oncology, Inc. She then served as the Senior Vice President of Research at Alpine Immune Sciences, Inc. Dr. Holland holds a doctorate degree from the University of Washington and an undergraduate degree from the University of California San Diego.
Former positions of Pamela Holland
| Companies | Position | End |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2023-04-30 |
| SURFACE ONCOLOGY, INC. | Corporate Officer/Principal | - |
Training of Pamela Holland
| University of California San Diego | Undergraduate Degree |
| University of Washington | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Surface Oncology, Inc.
 Surface Oncology, Inc. BiotechnologyHealth Technology Surface Oncology, Inc. operates as a clinical-stage immuno-oncology company, which engages in the provision of biological pathways critical to the immunosuppressive tumor microenvironment for the development of next-generation cancer therapies. The firm’s pipeline includes wholly-owned lead programs targeting CD39 (SRF617) and IL-27 (SRF388), as well as a preclinical program focused on depleting tumor regulatory T cells via targeting CCR8 (SRF114). Its pipeline also includes licensed product programs, such as a collaboration with Novartis targeting CD73 (NZV930, Phase 1) and a collaboration with GlaxoSmithKline targeting PVRIG (SRF813, preclinical). The company was founded by David S. Grayzel in 2014 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Pamela Holland
